Cvs Triple-thick Antibacterial Washcloths label

Cvs Triple-thick Antibacterial Washcloths

Cvs Triple-thick Antibacterial Washcloths Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

For external use only.

Do not use on

  • deep or puncture wounds
  • animal bites
  • serious burns

When using this product

  • do not get into eyes

Stop use and ask a doctor if

  • irritation or redness develops
  • conditions persist for more than 72 hours

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Do not use on

  • deep or puncture wounds
  • animal bites
  • serious burns

Stop use and ask a doctor if

  • irritation or redness develops
  • conditions persist for more than 72 hours

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

  • helps reduce germs that can potentially cause infection

History

There is currently no drug history available for this drug.

Other Information

There are no additional details available for this product.

Cvs Triple-thick Antibacterial Washcloths Manufacturers

  • Cvs Pharmacy
    Cvs Triple-thick Antibacterial Washcloths | Teva Pharmaceuticals Usa Inc
    No Recall

    Cvs Triple-thick Antibacterial Washcloths | Teva Pharmaceuticals Usa Inc

    Cvs Triple-thick Antibacterial Washcloths | Teva Pharmaceuticals Usa Inc

    Use the lowest effective dose for the patient.

    2.1 Dosage in Adults

    The recommended starting dose is 1 mg. Dosing can be raised to 2 mg or 3 mg if clinically indicated. In some patients, the higher morning blood levels of eszopiclone tablets following use of the 2 mg or 3 mg dose increase the risk of next day impairment of driving and other activities that require full alertness [see Warnings and Precautions (5.1)]. The total dose of eszopiclone tablets should not exceed 3 mg, once daily immediately before bedtime [see Warnings and Precautions (5.6)].

    2.2 Geriatric or Debilitated Patients

    The total dose of eszopiclone tablets should not exceed 2 mg in elderly or debilitated patients.

    2.3 Patients with Severe Hepatic Impairment, or Taking Potent CYP3A4 Inhibitors

    In patients with severe hepatic impairment, or in patients coadministered eszopiclone tablets with potent CYP3A4 inhibitors, the total dose of eszopiclone tablets should not exceed 2 mg [see Warning and Precautions (5.7)].

    2.4 Use with CNS Depressants

    Dosage adjustments may be necessary when eszopiclone tablets are combined with other CNS depressant drugs because of the potentially additive effects [see Warnings and Precautions (5.1)].

    2.5 Administration with Food

    Taking eszopiclone tablets with or immediately after a heavy, high-fat meal results in slower absorption and would be expected to reduce the effect of eszopiclone tablets on sleep latency [see Clinical Pharmacology (12.3)].